State-wise Number of Vials of Remdesivir, Tocilizumab and Amphotericin B Supplied for Treatment of COVID-19 Infections by Pharmaceutical Companies Against Allocation Given by Central Government in Hindi Belt of India (As on 25.07.2021) | |||
States/UTs | Remdesivir | Tocilizumab | Amphotericin B |
Bihar | |||
Chandigarh | |||
Chhattisgarh | |||
Delhi | |||
Haryana | |||
Himachal Pradesh | |||
Jharkhand | |||
Madhya Pradesh | |||
Rajasthan | |||
Uttar Pradesh | |||
Uttarakhand | |||
Hindi Belt | |||
India |